Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Jun 16, 2025
Cable Car Capital operates as a global opportunistic fund with eight custodians facilitating niche strategies across different regions. The fund has evolved into a more trading-oriented approach due to extreme volatility and price-value dislocations in equity markets characterized by broader retail participation. Key activities include active litigation with ten resolved matters involving contract enforcement and shareholder rights, SPAC-related litigation and structured financings, and biotech investments during the current downcycle. The manager served on the board of Arca Biopharma through its merger with Oruka Therapeutics, establishing a model for similar transactions. Currently, the fund is aggressively positioned in crypto Treasury strategies, capitalizing on public companies trading at premiums to net asset value through both PIPE commitments at discounts and synthetic put positions in MSTR via convertible bonds. The fund expects eventual compression of these premiums as new supply overwhelms demand. Cable Car continues expanding its structured finance capabilities and remains involved in multiple ongoing biotech strategic alternatives processes.
Cable Car Capital employs a global, opportunistic strategy focused on arbitrage situations, activist positions in small-cap biotechnology during downturns, SPAC-related litigation and structured financings, and capitalizing on crypto Treasury strategy dislocations through both long and short positions.
The manager expects eventual compression of crypto Treasury premiums to NAV as new supply overwhelms demand, though timing is unpredictable. They remain involved in several ongoing biotech strategic alternatives processes and continue active litigation strategies.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Cable Car Capital / Funicular Funds or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.